Ally Bridge Group (NY) LLC Quant / Systematic

Location: New York, NY

CIK: 0001822947 · Show all filings

Period: Q2 2026 (← Previous)

Filing Date: Aug 14, 2026

Total Value: $113M (100.0% shares, 0.0% debt)

Holdings (25)

DFTX DEFINIUM THERAPEUTICS INC 16.6%

Value $18.82M Shares 400,000 Est. Cost — Unrealized —

ABVX ABIVAX SA 14.7%

Value $16.66M Shares 125,000 Est. Cost — Unrealized —

NERV MINERVA NEUROSCIENCES INC 10.7%

Value $12.08M Shares 2,175,802 Est. Cost — Unrealized —

PMN PROMIS NEUROSCIENCES INC 7.2%

Value $8.163M Shares 620,319 Est. Cost — Unrealized —

TRAX FIRST TRACKS BIOTHERAPEUTICS 5.1%

Value $5.72M Shares 284,287 Est. Cost — Unrealized —

AXSM AXSOME THERAPEUTICS INC 3.6%

Value $4.037M Shares 16,493 Est. Cost — Unrealized —

ASMB ASSEMBLY BIOSCIENCES INC 3.4%

Value $3.847M Shares 140,000 Est. Cost — Unrealized —

WHWK WHITEHAWK THERAPEUTICS INC 3.3%

Value $3.746M Shares 817,939 Est. Cost — Unrealized —

EWTX EDGEWISE THERAPEUTICS INC 3.0%

Value $3.384M Shares 83,300 Est. Cost — Unrealized —

CLYM CLIMB BIO INC 2.9%

Value $3.249M Shares 249,172 Est. Cost — Unrealized —

KURA KURA ONCOLOGY INC 2.8%

Value $3.181M Shares 290,000 Est. Cost — Unrealized —

CTMX CYTOMX THERAPEUTICS INC. 2.6%

Value $2.906M Shares 775,000 Est. Cost — Unrealized —

AVTX AVALO THERAPEUTICS INC 2.5%

Value $2.772M Shares 150,000 Est. Cost — Unrealized —

PALI PALISADE BIO INC 2.3%

Value $2.569M Shares 1,229,000 Est. Cost — Unrealized —

SLDB SOLID BIOSCIENCES INC 2.3%

Value $2.557M Shares 255,959 Est. Cost — Unrealized —

ANTX AN2 THERAPEUTICS INC 2.3%

Value $2.547M Shares 526,315 Est. Cost — Unrealized —

URGN UROGEN PHARMA LTD 2.3%

Value $2.546M Shares 69,183 Est. Cost — Unrealized —

CATX PERSPECTIVE THERAPEUTICS INC 2.2%

Value $2.537M Shares 743,958 Est. Cost — Unrealized —

IDYA IDEAYA BIOSCIENCES INC 2.2%

Value $2.516M Shares 67,500 Est. Cost — Unrealized —

IVA INVENTIVA SA 2.1%

Value $2.4M Shares 634,800 Est. Cost — Unrealized —

ALMS ALUMIS INC 1.9%

Value $2.152M Shares 76,459 Est. Cost — Unrealized —

OVID OVID THERAPEUTICS INC 1.5%

Value $1.68M Shares 624,561 Est. Cost — Unrealized —

EPRX EUPRAXIA PHARMACEUTICALS INC 1.5%

Value $1.667M Shares 252,175 Est. Cost — Unrealized —

IBIO IBIO INC 0.6%

Value $683K Shares 390,147 Est. Cost — Unrealized —

TRAW TRAWS PHARMA INC 0.6%

Value $663K Shares 786,236 Est. Cost — Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
DFTX	DEFINIUM THERAPEUTICS INC	400,000	$18.82M	16.6%	—	—	Call	24477V105
ABVX	ABIVAX SA	125,000	$16.66M	14.7%	—	—	Call	00370M103
NERV	MINERVA NEUROSCIENCES INC	2,175,802	$12.08M	10.7%	—	—	COM NEW	603380205
PMN	PROMIS NEUROSCIENCES INC	620,319	$8.163M	7.2%	—	—	COM SHS	74346M505
TRAX	FIRST TRACKS BIOTHERAPEUTICS	284,287	$5.72M	5.1%	—	—	ORD SHS	337185102
AXSM	AXSOME THERAPEUTICS INC	16,493	$4.037M	3.6%	—	—	COM	05464T104
ASMB	ASSEMBLY BIOSCIENCES INC	140,000	$3.847M	3.4%	—	—	COM NEW	045396207
WHWK	WHITEHAWK THERAPEUTICS INC	817,939	$3.746M	3.3%	—	—	COM	00032Q104
EWTX	EDGEWISE THERAPEUTICS INC	83,300	$3.384M	3.0%	—	—	COM	28036F105
CLYM	CLIMB BIO INC	249,172	$3.249M	2.9%	—	—	COM	28658R106
KURA	KURA ONCOLOGY INC	290,000	$3.181M	2.8%	—	—	COM	50127T109
CTMX	CYTOMX THERAPEUTICS INC.	775,000	$2.906M	2.6%	—	—	COM	23284F105
AVTX	AVALO THERAPEUTICS INC	150,000	$2.772M	2.5%	—	—	SPONSORED ADS	05338F306
PALI	PALISADE BIO INC	1,229,000	$2.569M	2.3%	—	—	COM	696389402
SLDB	SOLID BIOSCIENCES INC	255,959	$2.557M	2.3%	—	—	COM	83422E204
ANTX	AN2 THERAPEUTICS INC	526,315	$2.547M	2.3%	—	—	COM	037326105
URGN	UROGEN PHARMA LTD	69,183	$2.546M	2.3%	—	—	COM	M96088105
CATX	PERSPECTIVE THERAPEUTICS INC	743,958	$2.537M	2.2%	—	—	COM NEW	46489V302
IDYA	IDEAYA BIOSCIENCES INC	67,500	$2.516M	2.2%	—	—	COM	45166A102
IVA	INVENTIVA SA	634,800	$2.4M	2.1%	—	—	ADS	46124U107
ALMS	ALUMIS INC	76,459	$2.152M	1.9%	—	—	COM	022307102
OVID	OVID THERAPEUTICS INC	624,561	$1.68M	1.5%	—	—	COM	690469101
EPRX	EUPRAXIA PHARMACEUTICALS INC	252,175	$1.667M	1.5%	—	—	COM	29842P105
IBIO	IBIO INC	390,147	$683K	0.6%	—	—	COM NEW	451033708
TRAW	TRAWS PHARMA INC	786,236	$663K	0.6%	—	—	COM	68232V884